Royal National Orthopaedic Hospital Trust Trust Board Meeting - Executive Summary Report/Paper: Integrated Performance Report (January 2010) Date: 25th February 2010 Purpose of Paper: To provide the Trust Board with an update on the 18 performance targets the Trust measures itself against. Summary of Paper: In addition to the Integrated Performance Report, appended to this Executive Summary are the following additional pieces of information: Appendix 1 – Director of Finance Report and supporting including: Key financial performance indicators Income & Expenditure Summary Balance Sheet Cash flow statement Appendix 2 – pressure sores chart Key points to draw from Integrated Performance Report: 1) MRSA/wound infections – 0 for January, 1 cumulatively; 2) Cdiff – 2 cases cumulatively; 3) Pressure Ulcers – 31 cumulatively; 4) 18 week target (including breach sharing) – Non-Admitted 94%; Admitted 88 %; 5) Breaches of current inpatient and outpatient access targets – 1 outpatient breach year to date; 6) Cancer targets – Provisional January performance 97% 2 week wait, 97% 31 day, 96% 31 day subsequent, 79% 62 day. 7) NHS Activity levels – 1% negative variance cumulatively; 8) Finance – £915k cumulative surplus; 9) 78% staff appraisals against target of 88%; 10) 3.70% rate of staff sickness against a target of 3.60%; 11) 100% compliant with the European Working Time Directive; 12) Percentage of cancelled operations – 1.4% against target of 1.5%; 13) No increase in cancellations after admission – 5.1% against target of 4.1%; 14) 15% reduction in new to follow up Outpatient ratio – 3.6 against target of 3.4 ; 15) 95% of theatre sessions used against an available target of 97% Action Required by the Board: Recommendation from Legal Advisors (if applicable): Author and position of Report/Paper Lead Director For Information Not applicable All Executive Directors All Executive Directors Links to Assurance Framework, Local Performance Targets and Corporate Strategic risk register: This paper/report links to the following principal objectives, local performance targets and the corporate strategic risks: - (please tick as appropriate) Principal Objectives Principal Objective One - Maintaining clinical excellence Tick as appropriate √ To be the pre-eminent, effective, efficient and safe provider of orthopaedic and musculoskeletal services, providing the highest standards of care. (Linked to performance target Q1,Q2,Q3, Q4, Q5, P1, P2, P3, P4 and corporate strategic risk: 463) Principal Objective Two - Re-development and capital investment To redevelop the RNOH Stanmore campus to provide a modern healthcare building and facilities. To effectively use capital investment to improve the working environment and health and safety. To improve and sustain business activity. (Linked to corporate strategic risks: 463, 467, 470, 472)) Principal Objective Three - Finance To achieve financial balance and maintain liquidity and increase turnover. (Linked to performance target F1 and corporate strategic risk: 468) Principal Objective Four - Leadership and workforce To ensure that the workforce is fit for purpose and supports the Trusts service and financial plans. (Linked to performance target M&L1, M&L2, M&L3 and corporate strategic risk: 465) Principal Objective Five – Governance To implement, embed and monitor effective arrangements that reflect current Trust business (Linked to corporate strategic risks: 464, 466) Principal Objective Six - Achievement of access/activity targets To achieve access targets and to deliver the activity targets. (Linked to performance target A1, A2, A3, A4, P1, P2, P 3, P 4 and corporate strategic risk: 463) Principal Objective Seven - IM&T Develop and implement a cohesive and integrated IM&T strategy. (Linked to corporate strategic risk: 471) Principal Objective Eight - Foundation Trust To achieve Foundation Trust status. (Linked to corporate strategic risks: 463, 467, 469, 472) Key: Q – Quality targets A – Access targets D – Financial targets M&L - Management & Leadership targets P – Productivity targets √ √ √ √ √ √ √